HSBC plans one-year return enhanced notes linked to four stocks

By Susanna Moon

Chicago, Jan. 29 - HSBC USA Inc. plans to price 0% return enhanced notes due Feb. 19, 2015 linked to a basket of four equally weighted stocks, according to an FWP filing with the Securities and Exchange Commission.

The underlying companies are Actavis plc, Endo Health Solutions Inc., Mylan Inc. and Valeant Pharmaceuticals International, Inc.

The payout at maturity will be par plus 1.5 times any gain in the basket, up to a maximum return of 25.5%.

Investors will be exposed to any losses.

HSBC Securities (USA) Inc. is the underwriter, and J.P. Morgan Securities LLC is the agent.

The notes will price on Jan. 31 and settle on Feb. 5.

The Cusip number is 40432XSA0.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.